Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析

◆英語タイトル:Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15754
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Integra LifeSciences Holdings Corp (IART) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and an extensive network of distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp Key Recent Developments

Mar 14,2019 Integra LifeSciences Announces the Approval of DuraGen® in Japan | Integra LifeSciences Holdings Corporation
Feb 21,2019 Integra LifeSciences reports fourth quarter and full-year 2018 financial results and provides 2019 financial guidance
Jan 09,2019 Integra LifeSciences appoints Rhonda Germany Ballintyn as Director
Jan 09,2019 Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director | Integra LifeSciences Holdings Corporation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Integra LifeSciences Holdings Corp – Key Facts
Integra LifeSciences Holdings Corp – Key Employees
Integra LifeSciences Holdings Corp – Key Employee Biographies
Integra LifeSciences Holdings Corp – Major Products and Services
Integra LifeSciences Holdings Corp – History
Integra LifeSciences Holdings Corp – Company Statement
Integra LifeSciences Holdings Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Integra LifeSciences Holdings Corp – Business Description
Business Segment: Codman Specialty Surgical
Overview
Performance
Business Segment: Orthopedics and Tissue Technologies
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Integra LifeSciences Holdings Corp – Corporate Strategy
Integra LifeSciences Holdings Corp – SWOT Analysis
SWOT Analysis – Overview
Integra LifeSciences Holdings Corp – Strengths
Integra LifeSciences Holdings Corp – Weaknesses
Integra LifeSciences Holdings Corp – Opportunities
Integra LifeSciences Holdings Corp – Threats
Integra LifeSciences Holdings Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 14, 2019: Integra LifeSciences Announces the Approval of DuraGen® in Japan | Integra LifeSciences Holdings Corporation
Feb 21, 2019: Integra LifeSciences reports fourth quarter and full-year 2018 financial results and provides 2019 financial guidance
Jan 09, 2019: Integra LifeSciences appoints Rhonda Germany Ballintyn as Director
Jan 09, 2019: Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director | Integra LifeSciences Holdings Corporation
Jan 08, 2019: Integra LifeSciences announces preliminary fourth quarter 2018 financial results
Nov 20, 2018: Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
Oct 31, 2018: Integra LifeSciences reports third quarter 2018 financial results
Sep 05, 2018: 2018 Veeva R&D summit to showcase advances for speeding product development
Jul 25, 2018: Integra LifeSciences Reports Second Quarter 2018 Financial Results
May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Integra LifeSciences Holdings Corp, Key Facts
Integra LifeSciences Holdings Corp, Key Employees
Integra LifeSciences Holdings Corp, Key Employee Biographies
Integra LifeSciences Holdings Corp, Major Products and Services
Integra LifeSciences Holdings Corp, History
Integra LifeSciences Holdings Corp, Other Locations
Integra LifeSciences Holdings Corp, Subsidiaries
Integra LifeSciences Holdings Corp, Key Competitors
Integra LifeSciences Holdings Corp, Ratios based on current share price
Integra LifeSciences Holdings Corp, Annual Ratios
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...1)
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...2)
Integra LifeSciences Holdings Corp, Interim Ratios
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Integra LifeSciences Holdings Corp, Performance Chart (2014 - 2018)
Integra LifeSciences Holdings Corp, Ratio Charts
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yamato Holdings Co Ltd (9064):企業の財務・戦略的SWOT分析
    Yamato Holdings Co Ltd (9064) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • LifeAssays AB (LIFE B)-医療機器分野:企業M&A・提携分析
    Summary LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company provides point-of-care diagnostic testing systems. Its product portfolio includes lifeassays human system and lifeassays veterinary sys …
  • Xylem Inc (XYL):石油・ガス:M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …
  • RattanIndia Power Ltd (RTNPOWER):電力:M&Aディール及び事業提携情報
    Summary RattanIndia Power Ltd (RattanIndia Power), formerly Sophia Power Company Ltd is a power company that constructs, develops, operates, and manages thermal power projects across India. The company offers renewable energy solutions, operation and management of power plants, and project managemen …
  • Repsol SA (REP):企業の財務・戦略的SWOT分析
    Repsol SA (REP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Pioneer Corp:企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Immunodiagnostic Systems Holdings plc (IDH):医療機器:M&Aディール及び事業提携情報
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Diamond Offshore Drilling Inc (DO):企業の財務・戦略的SWOT分析
    Diamond Offshore Drilling Inc (DO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務情報
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Supernus Pharmaceuticals Inc (SUPN)-製薬・医療分野:企業M&A・提携分析
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …
  • CK Hutchison Holdings Ltd:企業のM&A・事業提携・投資動向
    CK Hutchison Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CK Hutchison Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Evofem Inc-医療機器分野:企業M&A・提携分析
    Summary Evofem Inc (Evofem) is a healthcare solution provider that discovers, develops and commercializes prescription and consumer products. The company’s product pipeline includes amphora and nestorone. Evofem improves reproductive health and wellness options for women. It develops products for co …
  • Spark Therapeutics Inc (ONCE):企業の財務・戦略的SWOT分析
    Summary Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1 …
  • AFT Pharmaceuticals Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AFT Pharmaceuticals Pty Ltd (AFT Pharmaceuticals) is a manufacturer and distributor medical products. The company provides prescription and non-prescription products. Its products include moisturizers, calcium supplements, scalp ointments, eye drops, cracked heel creams, iron and folic acid …
  • Luitpold Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Luitpold Pharmaceuticals Inc (Luitpold Pharmaceuticals), a subsidiary of Daiichi Sankyo Co Ltd is a manufacturer and marketer of drugs and medical devices. The company provides products such as injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, cri …
  • Gateway Lifestyle Group:企業の戦略・SWOT・財務情報
    Gateway Lifestyle Group - Strategy, SWOT and Corporate Finance Report Summary Gateway Lifestyle Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Monogram Biosciences Inc:企業の戦略的SWOT分析
    Monogram Biosciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • BioMotiv LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pi …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Riemser Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products provider that markets and sells lifecycle management products. The company offers analgesics, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. Its products inc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆